Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Jun;11(2):e53-6.
doi: 10.1007/BF03327760.

Olanzapine use in adolescent anorexia nervosa

K Dennis  1 , D Le Grange, J Bremer
Affiliations
Case Reports

Olanzapine use in adolescent anorexia nervosa

K Dennis et al. Eat Weight Disord. 2006 Jun.

Abstract

Several case reports and open label trials describe olanzapine in the treatment of anorexia nervosa (AN). We report 5 adolescents with AN who received olanzapine in addition to psychotherapy for their eating disorder. Body mass index (BMI) of each case increased while on olanzapine. At doses of 5 mg per day and above, patients reported decreased anxiety around eating, improved sleep, and decreased rumination about food and body concerns. Morning sedation was the most commonly reported adverse effect. Olanzapine appeared to be useful in addition to psychotherapy for these adolescents. This report augments a limited literature on the treatment of this disorder, and an almost nonexistent literature specific to pharmacotherapy for adolescents with AN.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Australas Psychiatry. 2005 Mar;13(1):72-5 - PubMed
    1. J Clin Psychiatry. 1991 Dec;52 Suppl:41-8 - PubMed
    1. Int J Eat Disord. 2001 Jul;30(1):57-68 - PubMed
    1. Int J Eat Disord. 2002 Sep;32(2):146-54 - PubMed
    1. Arch Gen Psychiatry. 1961 Jun;4:561-71 - PubMed

Publication types